Cross Country Healthcare (CCRN) Competitors

$13.14 +0.03 (+0.19%)

As of 01:50 PM Eastern

CCRN vs. AMN, DGX, LH, DVA, and CHE

Should you be buying Cross Country Healthcare stock or one of its competitors? The main competitors of Cross Country Healthcare include AMN Healthcare Services (AMN), Quest Diagnostics (DGX), Labcorp (LH), DaVita (DVA), and Chemed (CHE). These companies are all part of the "health care services" industry.

How does Cross Country Healthcare compare to AMN Healthcare Services?

Cross Country Healthcare (NASDAQ:CCRN) and AMN Healthcare Services (NYSE:AMN) are both small-cap health care services companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

AMN Healthcare Services has a net margin of -0.95% compared to Cross Country Healthcare's net margin of -9.84%. AMN Healthcare Services' return on equity of 18.01% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
AMN Healthcare Services	-0.95%	18.01%	5.19%

Cross Country Healthcare has a beta of 0.35, suggesting that its stock price is 65% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market.

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Cross Country Healthcare has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Cross Country Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A
AMN Healthcare Services	$2.73B	0.43	-$95.70M	-$0.87	N/A

Cross Country Healthcare currently has a consensus target price of $12.72, indicating a potential downside of 3.23%. AMN Healthcare Services has a consensus target price of $23.50, indicating a potential downside of 21.93%. Given Cross Country Healthcare's higher possible upside, analysts plainly believe Cross Country Healthcare is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
AMN Healthcare Services	2 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.44

In the previous week, Cross Country Healthcare had 7 more articles in the media than AMN Healthcare Services. MarketBeat recorded 24 mentions for Cross Country Healthcare and 17 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.69 beat Cross Country Healthcare's score of -0.02 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	1 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Neutral
AMN Healthcare Services	4 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

AMN Healthcare Services beats Cross Country Healthcare on 11 of the 17 factors compared between the two stocks.

How does Cross Country Healthcare compare to Quest Diagnostics?

Cross Country Healthcare (NASDAQ:CCRN) and Quest Diagnostics (NYSE:DGX) are both health care services companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by company insiders. Comparatively, 0.9% of Quest Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Quest Diagnostics has a net margin of 9.07% compared to Cross Country Healthcare's net margin of -9.84%. Quest Diagnostics' return on equity of 15.60% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
Quest Diagnostics	9.07%	15.60%	7.06%

Quest Diagnostics has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A
Quest Diagnostics	$11.04B	1.92	$992M	$9.05	21.17

In the previous week, Cross Country Healthcare had 16 more articles in the media than Quest Diagnostics. MarketBeat recorded 24 mentions for Cross Country Healthcare and 8 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 1.00 beat Cross Country Healthcare's score of -0.02 indicating that Quest Diagnostics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	1 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Neutral
Quest Diagnostics	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Cross Country Healthcare has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market.

Cross Country Healthcare currently has a consensus price target of $12.72, indicating a potential downside of 3.23%. Quest Diagnostics has a consensus price target of $216.58, indicating a potential upside of 13.05%. Given Quest Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe Quest Diagnostics is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Quest Diagnostics beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to Labcorp?

Labcorp (NYSE:LH) and Cross Country Healthcare (NASDAQ:CCRN) are both health care services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

95.9% of Labcorp shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 0.8% of Labcorp shares are owned by insiders. Comparatively, 6.3% of Cross Country Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Labcorp has a net margin of 6.66% compared to Cross Country Healthcare's net margin of -9.84%. Labcorp's return on equity of 16.29% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Labcorp	6.66%	16.29%	7.62%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

Labcorp has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$13.95B	1.52	$876.50M	$11.29	22.86
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A

In the previous week, Cross Country Healthcare had 15 more articles in the media than Labcorp. MarketBeat recorded 24 mentions for Cross Country Healthcare and 9 mentions for Labcorp. Labcorp's average media sentiment score of 0.73 beat Cross Country Healthcare's score of -0.02 indicating that Labcorp is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Labcorp	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cross Country Healthcare	1 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Neutral

Labcorp has a beta of 0.91, suggesting that its stock price is 9% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.35, suggesting that its stock price is 65% less volatile than the broader market.

Labcorp presently has a consensus price target of $308.00, indicating a potential upside of 19.35%. Cross Country Healthcare has a consensus price target of $12.72, indicating a potential downside of 3.23%. Given Labcorp's stronger consensus rating and higher probable upside, analysts plainly believe Labcorp is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

Summary

Labcorp beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks.

How does Cross Country Healthcare compare to DaVita?

Cross Country Healthcare (NASDAQ:CCRN) and DaVita (NYSE:DVA) are both health care services companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

Cross Country Healthcare presently has a consensus price target of $12.72, suggesting a potential downside of 3.23%. DaVita has a consensus price target of $199.17, suggesting a potential downside of 1.03%. Given DaVita's stronger consensus rating and higher possible upside, analysts plainly believe DaVita is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
DaVita	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.38

DaVita has a net margin of 5.65% compared to Cross Country Healthcare's net margin of -9.84%. Cross Country Healthcare's return on equity of -0.74% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
DaVita	5.65%	-270.37%	4.87%

96.0% of Cross Country Healthcare shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 6.3% of Cross Country Healthcare shares are owned by company insiders. Comparatively, 1.5% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

DaVita has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A
DaVita	$13.64B	0.95	$746.80M	$10.78	18.67

Cross Country Healthcare has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, DaVita has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market.

In the previous week, DaVita had 15 more articles in the media than Cross Country Healthcare. MarketBeat recorded 39 mentions for DaVita and 24 mentions for Cross Country Healthcare. DaVita's average media sentiment score of 0.79 beat Cross Country Healthcare's score of -0.02 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	1 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Neutral
DaVita	14 Very Positive mention(s)	3 Positive mention(s)	14 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DaVita beats Cross Country Healthcare on 14 of the 17 factors compared between the two stocks.

How does Cross Country Healthcare compare to Chemed?

Cross Country Healthcare (NASDAQ:CCRN) and Chemed (NYSE:CHE) are both health care services companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

Cross Country Healthcare presently has a consensus price target of $12.72, suggesting a potential downside of 3.23%. Chemed has a consensus price target of $501.50, suggesting a potential upside of 19.56%. Given Chemed's stronger consensus rating and higher possible upside, analysts plainly believe Chemed is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
Chemed	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Chemed has a net margin of 10.23% compared to Cross Country Healthcare's net margin of -9.84%. Chemed's return on equity of 27.18% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
Chemed	10.23%	27.18%	17.38%

96.0% of Cross Country Healthcare shares are owned by institutional investors. Comparatively, 95.9% of Chemed shares are owned by institutional investors. 6.3% of Cross Country Healthcare shares are owned by company insiders. Comparatively, 3.3% of Chemed shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Chemed has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A
Chemed	$2.53B	2.20	$265.24M	$18.35	22.86

Cross Country Healthcare has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, Chemed has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

In the previous week, Cross Country Healthcare had 21 more articles in the media than Chemed. MarketBeat recorded 24 mentions for Cross Country Healthcare and 3 mentions for Chemed. Chemed's average media sentiment score of 1.53 beat Cross Country Healthcare's score of -0.02 indicating that Chemed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	1 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Neutral
Chemed	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Chemed beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks.

Get Cross Country Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCRN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCRN vs. The Competition

Export

Metric	Cross Country Healthcare	Staffing Industry	Business Sector	NASDAQ Exchange
Market Cap	$423.27M	$1.05B	$6.34B	$12.04B
Dividend Yield	N/A	4.30%	3.04%	5.23%
P/E Ratio	-4.31	12.89	29.97	25.22
Price / Sales	0.40	0.61	440.56	74.60
Price / Cash	24.98	10.92	22.61	36.29
Price / Book	1.33	3.12	6.09	6.58
Net Income	-$94.85M	-$12.00M	$200.03M	$333.40M
7 Day Performance	23.20%	-1.31%	-1.66%	-0.99%
1 Month Performance	38.66%	7.64%	4.41%	7.15%
1 Year Performance	-5.57%	-12.63%	39.12%	34.19%

Cross Country Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCRN Cross Country Healthcare	2.2432 of 5 stars	$13.15 +0.2%	$12.72 -3.2%	-6.5%	$423.27M	$1.05B	N/A	6,784	Earnings Report Analyst Forecast
AMN AMN Healthcare Services	1.2894 of 5 stars	$20.76 -1.7%	$22.64 +9.0%	+38.4%	$816.10M	$2.73B	N/A	2,664	Earnings Report Analyst Forecast
DGX Quest Diagnostics	4.7735 of 5 stars	$191.66 -0.5%	$214.54 +11.9%	+7.3%	$21.33B	$11.04B	21.18	57,000
LH Labcorp	4.5647 of 5 stars	$252.99 -1.1%	$308.00 +21.7%	+3.8%	$21.03B	$14.14B	22.41	71,000
DVA DaVita	3.2808 of 5 stars	$154.15 +1.6%	$155.80 +1.1%	+38.5%	$10.13B	$13.64B	15.56	78,000	Trending News Earnings Report Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CCRN) was last updated on 5/12/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cross Country Healthcare (CCRN) Competitors

CCRN vs. AMN, DGX, LH, DVA, and CHE

How does Cross Country Healthcare compare to AMN Healthcare Services?

Summary

How does Cross Country Healthcare compare to Quest Diagnostics?

Summary

How does Cross Country Healthcare compare to Labcorp?

Summary

How does Cross Country Healthcare compare to DaVita?

Summary

How does Cross Country Healthcare compare to Chemed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCRN vs. The Competition

Cross Country Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cross Country Healthcare (CCRN) Competitors

CCRN vs. AMN, DGX, LH, DVA, and CHE

How does Cross Country Healthcare compare to AMN Healthcare Services?

Is CCRN or AMN more profitable?

Which has more risk & volatility, CCRN or AMN?

Do insiders & institutionals believe in CCRN or AMN?

Which has higher earnings & valuation, CCRN or AMN?

Do analysts rate CCRN or AMN?

Does the media prefer CCRN or AMN?

Summary

How does Cross Country Healthcare compare to Quest Diagnostics?

Do institutionals & insiders believe in CCRN or DGX?

Is CCRN or DGX more profitable?

Which has stronger earnings and valuation, CCRN or DGX?

Does the media prefer CCRN or DGX?

Which has more risk and volatility, CCRN or DGX?

Do analysts recommend CCRN or DGX?

Summary

How does Cross Country Healthcare compare to Labcorp?

Do insiders and institutionals have more ownership in LH or CCRN?

Is LH or CCRN more profitable?

Which has stronger earnings and valuation, LH or CCRN?

Does the media refer more to LH or CCRN?

Which has more volatility and risk, LH or CCRN?

Do analysts rate LH or CCRN?

Summary

How does Cross Country Healthcare compare to DaVita?

Do analysts rate CCRN or DVA?

Is CCRN or DVA more profitable?

Do institutionals and insiders have more ownership in CCRN or DVA?

Which has higher valuation & earnings, CCRN or DVA?

Which has more risk and volatility, CCRN or DVA?

Does the media refer more to CCRN or DVA?

Summary

How does Cross Country Healthcare compare to Chemed?

Do analysts rate CCRN or CHE?

Is CCRN or CHE more profitable?

Do institutionals and insiders have more ownership in CCRN or CHE?

Which has higher valuation & earnings, CCRN or CHE?

Which has more risk and volatility, CCRN or CHE?

Does the media refer more to CCRN or CHE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCRN vs. The Competition

Cross Country Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools